After the investigator has taken the decision to use human insulin or insulin analogues to treat the subject, any type 2 diabetic previously inadequately controlled with two or more OADs is eligible for the study 
The selection of the subjects will be at the discretion of the individual investigator 

NCT00806936_inc_T1
Condition
type 2 diabetic
NCT00806936_inc_T2
Qualifier
inadequately controlled
NCT00806936_inc_T3
Temporal
previously
NCT00806936_inc_T4
Multiplier
two or more
NCT00806936_inc_T5
Condition
OADs